Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Luca Cantarini »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Luca Brunese < Luca Cantarini < Luca Castagna  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000830 (2013) Gaia Vannucci [Oman] ; Luca Cantarini ; Teresa Giani ; Edoardo Marrani ; Davide Moretti ; Ilaria Pagnini ; Gabriele Simonini ; Rolando CimazGlucocorticoids in the management of systemic juvenile idiopathic arthritis.
000A75 (2014) Luisa Costa [Italie] ; Francesco Caso ; Luca Cantarini ; Antonio Del Puente ; Raffaele Scarpa ; Mariangela AttenoEfficacy of tocilizumab in a patient with refractory psoriatic arthritis.
000A85 (2015) Luca Cantarini [Oman] ; Giuseppe Lopalco ; Antonio Vitale ; Laura Coladonato ; Donato Rigante ; Orso Maria Lucherini ; Giovanni Lapadula ; Florenzo IannoneParadoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.
000B67 (2014) Francesco Caso [Italie] ; Luisa Costa [Italie] ; Donato Rigante [Italie] ; Orso Maria Lucherini [Italie] ; Paolo Caso [Italie] ; Vittoria Bascherini [Italie] ; Bruno Frediani [Italie] ; Rolando Cimaz [Italie] ; Edoardo Marrani [Italie] ; Laura Nieves-Martín [Espagne] ; Mariangela Atteno [Italie] ; Carmela G L. Raffaele [Italie] ; Giusyda Tarantino [Italie] ; Mauro Galeazzi [Italie] ; Leonardo Punzi [Italie] ; Luca Cantarini [Italie]Biological treatments in Behçet's disease: beyond anti-TNF therapy.
000C82 (2015) Carlo Selmi [Italie] ; Angela Ceribelli ; Stanley M. Naguwa ; Luca Cantarini ; Yehuda ShoenfeldSafety issues and concerns of new immunomodulators in rheumatology.
000D62 (2015) Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Antonio Vitale [Italie] ; Florenzo Iannone [Italie] ; Maria Grazia Anelli [Italie] ; Laura Andreozzi [Italie] ; Giovanni Lapadula [Italie] ; Mauro Galeazzi [Italie] ; Donato Rigante [Italie]Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
000E37 (2015) Francesco La Torre [Italie] ; Maurizio Muratore [Italie] ; Antonio Vitale [Italie] ; Fulvio Moramarco [Italie] ; Laura Quarta [Italie] ; Luca Cantarini [Italie]Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
000F87 (2016) Florenzo Iannone [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis.
001057 (2016) Florenzo Iannone [Italie] ; Giuseppe Lopalco [Italie] ; Donato Rigante [Italie] ; Ida Orlando [Italie] ; Luca Cantarini [Italie] ; Giovanni Lapadula [Italie]Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy.
001077 (????) Florenzo Iannone [Italie] ; Marilina Tampoia [Italie] ; Margherita Giannini [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; C Danilo Villalta [Italie] ; Mauro Galeazzi [Italie] ; Giovanni Lapadula [Italie]Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.
001142 (2016) Giacomo Emmi [Italie] ; Elena Silvestri [Italie] ; Danilo Squatrito [Italie] ; Lorenzo Emmi [Italie] ; Luca Cantarini [Italie] ; Domenico Prisco [Italie]Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet׳s disease.
001171 (2016) Antonio Vitale [Italie] ; Donato Rigante [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Maria Teresa Bianco [Italie] ; Mauro Galeazzi [Italie] ; Florenzo Iannone [Italie] ; Luca Cantarini [Italie]New therapeutic solutions for Behçet's syndrome.
001382 (2016) Antonio Vitale [Italie] ; Antonella Insalaco [Italie] ; Paolo Sfriso [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Marco Cattalini [Italie] ; Raffaele Manna [Italie] ; Rolando Cimaz [Italie] ; Roberta Priori [Italie] ; Rosaria Talarico [Italie] ; Stefano Gentileschi [Italie] ; Ginevra De Marchi [Italie] ; Micol Frassi [Italie] ; Romina Gallizzi [Italie] ; Alessandra Soriano [Italie] ; Maria Alessio [Italie] ; Daniele Cammelli [Italie] ; Maria C. Maggio [Italie] ; Renzo Marcolongo [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Serena Colafrancesco [Italie] ; Francesca Ricci [Italie] ; Paola Galozzi [Italie] ; Ombretta Viapiana [Italie] ; Elena Verrecchia [Italie] ; Manuela Pardeo [Italie] ; Lucia Cerrito [Italie] ; Elena Cavallaro [Italie] ; Alma N. Olivieri [Italie] ; Giuseppe Paolazzi [Italie] ; Gianfranco Vitiello [Italie] ; Armin Maier [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Guido Valesini [Italie] ; Marta Mosca [Italie] ; Salvatore De Vita [Italie] ; Angela Tincani [Italie] ; Giovanni Lapadula [Italie] ; Bruno Frediani [Italie] ; Fabrizio De Benedetti [Italie] ; Florenzo Iannone [Italie] ; Leonardo Punzi [Italie] ; Carlo Salvarani [Italie] ; Mauro Galeazzi [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
001409 (????) Liliana Dinoia [Italie] ; Giuseppe Lopalco [Italie] ; Luca Cantarini [Italie] ; Loreto Gesualdo [Italie] ; Michele Rossini [Italie] ; Florenzo Iannone [Italie]Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis.
001593 (2017) Giuseppe Lopalco [Italie] ; Claudia Fabiani [Italie] ; Jurgen Sota [Italie] ; Orso Maria Lucherini [Italie] ; Gian Marco Tosi [Italie] ; Bruno Frediani [Italie] ; Florenzo Iannone [Italie] ; Mauro Galeazzi [Italie] ; Rossella Franceschini [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]IL-6 blockade in the management of non-infectious uveitis.
001639 (2017) Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Luca Cantarini [Italie] ; Elena Cavallaro [Italie] ; Giulio Cavalli [Italie] ; Lucia Cerrito [Italie] ; Paola Cipriani [Italie] ; Lorenzo Dagna [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Gianfranco Ferraccioli [Italie] ; Micol Frassi [Italie] ; Mauro Galeazzi [Italie] ; Roberto Gerli [Italie] ; Roberto Giacomelli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Giovanni Lapadula [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Piero Ruscitti [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Francesca Fabris [Italie] ; Sara Bindoli [Italie] ; Leonardo Punzi [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie]Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
001D79 (2019) Jurgen Sota [Italie] ; Antonella Insalaco [Italie] ; Rolando Cimaz [Italie] ; Maria Alessio [Italie] ; Marco Cattalini [Italie] ; Romina Gallizzi [Italie] ; Maria Cristina Maggio [Italie] ; Giuseppe Lopalco [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Manuela Pardeo [Italie] ; Alma Nunzia Olivieri [Italie] ; Paolo Sfriso [Italie] ; Carlo Salvarani [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Claudia Bracaglia [Italie] ; Fabrizio De Benedetti [Italie] ; Donato Rigante [Italie] ; Luca Cantarini [Italie]Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
001F02 (2019) Alessandra Bettiol ; Giuseppe Lopalco ; Giacomo Emmi ; Luca Cantarini ; Maria Letizia Urban ; Antonio Vitale ; Nunzio Denora ; Antonio Lopalco ; Annalisa Cutrignelli ; Angela Lopedota ; Vincenzo Venerito ; Marco Fornaro ; Alfredo Vannacci ; Donato Rigante [Italie] ; Rolando Cimaz ; Florenzo IannoneUnveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
001F04 (2019) Antonio Vitale [Italie] ; Giulio Cavalli [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Guido Valesini [Italie] ; Lorenza Maria Argolini [Italie] ; Elena Baldissera [Italie] ; Elena Bartoloni [Italie] ; Daniele Cammelli [Italie] ; Giovanni Canestrari [Italie] ; Jurgen Sota [Italie] ; Elena Cavallaro [Italie] ; Maria Grazia Massaro [Italie] ; Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Ginevra De Marchi [Italie] ; Salvatore De Vita [Italie] ; Giacomo Emmi [Italie] ; Gianfranco Ferraccioli [Italie] ; Micol Frassi [Italie] ; Roberto Gerli [Italie] ; Elisa Gremese [Italie] ; Florenzo Iannone [Italie] ; Giovanni Lapadula [Italie] ; Giuseppe Lopalco [Italie] ; Raffaele Manna [Italie] ; Alessandro Mathieu [Italie] ; Carlomaurizio Montecucco [Italie] ; Marta Mosca [Italie] ; Ilaria Piazza [Italie] ; Matteo Piga [Italie] ; Irene Pontikaki [Italie] ; Micol Romano [Italie] ; Silvia Rossi [Italie] ; Maurizio Rossini [Italie] ; Elena Silvestri [Italie] ; Chiara Stagnaro [Italie] ; Rosaria Talarico [Italie] ; Angela Tincani [Italie] ; Ombretta Viapiana [Italie] ; Gianfranco Vitiello [Italie] ; Paola Galozzi [Italie] ; Paolo Sfriso [Italie] ; Carla Gaggiano [Italie] ; Donato Rigante [Italie] ; Lorenzo Dagna [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie]Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response
002350 (2019) Jurgen Sota [Italie] ; Donato Rigante [Italie] ; Piero Ruscitti [Italie] ; Antonella Insalaco [Italie] ; Paolo Sfriso [Italie] ; Salvatore De Vita [Italie] ; Rolando Cimaz [Italie] ; Giuseppe Lopalco [Italie] ; Giacomo Emmi [Italie] ; Francesco La Torre [Italie] ; Claudia Fabiani [Italie] ; Alma Nunzia Olivieri [Italie] ; Marco Cattalini [Italie] ; Daniele Cammelli [Italie] ; Romina Gallizzi [Italie] ; Maria Alessio [Italie] ; Raffaele Manna [Italie] ; Ombretta Viapiana [Italie] ; Micol Frassi [Italie] ; Manuela Pardeo [Italie] ; Armin Maier [Italie] ; Carlo Salvarani [Italie] ; Rosaria Talarico [Italie] ; Marta Mosca [Italie] ; Serena Colafrancesco [Italie] ; Roberta Priori [Italie] ; Maria Cristina Maggio [Italie] ; Carla Gaggiano [Italie] ; Salvatore Grosso [Italie] ; Fabrizio De Benedetti [Italie] ; Antonio Vitale [Italie] ; Roberto Giacomelli [Italie] ; Luca Cantarini [Italie]Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
002674 (2019) Serena Colafrancesco [Italie] ; Maria Manara [Italie] ; Alessandra Bortoluzzi ; Teodora Serban [Italie] ; Gerolamo Bianchi [Italie] ; Luca Cantarini [Italie] ; Francesco Ciccia [Italie] ; Lorenzo Dagna [Italie] ; Marcello Govoni ; Carlomaurizio Montecucco [Italie] ; Roberta Priori [Italie] ; Angelo Ravelli [Italie] ; Paolo Sfriso [Italie] ; Luigi Sinigaglia [Italie]Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Luca Cantarini" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Luca Cantarini" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Luca Cantarini
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021